The largest database of trusted experimental protocols

551 protocols using mtesr1

1

Feeder-free hESCs Culture and Passage

Check if the same lab product or an alternative is used in the 5 most similar protocols
hESCs were maintained in the feeder-free cell culture medium mTeSR1 (STEMCELL Technologies) with daily media changes. For passaging, cells were dissociated en bloc with ReLeSR (STEMCELL Technologies) following the manufacturer’s protocol, and detached ES cell clumps were broken into smaller pieces (10–20 cells) by tapping the plate or gently pipetting several times with a wide-bore P1000 micropipette (Corning). Cells were passaged at a 1:12 split ratio onto Matrigel-coated (Corning) plates. Immediately following passage, cells were maintained in mTeSR1 supplemented with 10 µM ROCK inhibitor Y-27632 (STEMCELL Technologies) for 24 h before returning to culture in mTeSR1 alone.
+ Open protocol
+ Expand
2

Feeder-free Expansion of Human iPSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Hepatic fibroblast derived iPS line ATCC-HYS0103 Human Induced Pluripotent Stem (IPS) Cells were purchased directly from the vendor. hESC-Qualified Matrigel (Corning 354277) Matrigel was used coat culture dishes for feeder-free expansion of induced pluripotent stem cells and were routinely cultured and maintained in mTeSR™1 (STEMCELL Technologies, 85850) in a humidified incubator at 37 °C with 5% CO2. Cells were passaged once a week using selective dissociation reagent ReLeSR™ (STEMCELL Technologies 05872) and seeded using the cell aggregate counting method described in 'Plating Human ES and iPS Cells Using the Cell Aggregate Count Method' (Appendix 1) from the STEMCELL Technologies-'Maintenance of Human Pluripotent Stem Cells in mTeSR™1' technical handbook to assess the size of aggregates and seed them in low, medium or high densities, as described. All cryopreservation of cells was performed in CryoStor® CS10 (STEMCELL Technologies 07930) freezing media.
For the glass controls in the experiments -sterile rh-Vitronectin (Gibco, Life Technologies, A14700) was used to coat glass cover slips. In case of all experiments, cells were dissociated into a single cell suspension using StemPro™ Accutase™ (Gibco A1110501) cell dissociation reagent to facilitate cell counting. In case of single cell dissociation, cells were always seeded with 10uM Rock inhibitor Y27632 (ATCC® ACS-3030™).
+ Open protocol
+ Expand
3

Stem Cell Culture Optimization

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cell culture dishes were monitored for confluency before starting the experiment. All experiments were performed using in mTeSR1 (STEMCELL Technologies, 85850). The cells were dissociated using warm StemPro Accutase (Gibco A1110501) cell dissociation reagent for 6–7 min. Cells were counted using a hemocytometer and seeded in mTeSR1 (STEMCELL Technologies, 85850) and a density of 5 × 105 cells mL−1 as a 1 mL per well solution in a 12‐well culture dish with 10 µm Rock inhibitor Y27632 (ATCC ACS‐3030). The medium was replaced with media without Y‐27632 at 24 h for 10 and 100 kPa substrates, and 5 µm Y‐27632 in case of 1 kPa substrates (This was completely removed at 36 h). The cells were allowed to grow on the 4 substrate groups for 48 h.
For BMP4 induction experiments, same seeding method was used, fresh media supplemented with rhBMP4 (STEMCELL Technologies, 78211) at a final concentration of 50 ng mL−1 on the 4 substrate groups for 48 h.
For small molecule and protein inhibitor treatments— cell cultures were supplemented with the following concentration of each agent at 6 h of seeding—CHIR99021 (3 µm), SB431542 (5 µm), IWP‐2 (2.5 µm), DKK1 (500 ng mL−1), sFRP1 (5 µg mL−1), Peptide17 (100 nm).
+ Open protocol
+ Expand
4

Feeder-Free Expansion of Human Induced Pluripotent Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Hepatic fibroblast derived iPS line ATCC‐HYS0103 Human Induced Pluripotent Stem (IPS) Cells were purchased directly from the vendor. hESC‐Qualified Matrigel (Corning 354277) was used coat culture dishes for feeder‐free expansion of induced pluripotent stem cells and were routinely cultured and maintained in mTeSR1 (STEMCELL Technologies, 85850) in a humidified incubator at 37 °C with 5% CO2. Cells were passaged once a week using selective dissociation reagent ReLeSR (STEMCELL Technologies 05872) and seeded using the cell aggregate counting method described in “Plating Human ES and iPS Cells Using the Cell Aggregate Count Method” (Appendix 1) from the STEMCELL Technologies—“Maintenance of Human Pluripotent Stem Cells in mTeSR1” technical handbook to assess the size of aggregates and seed them in low, medium or high densities, as described. All cryopreservation of cells was performed in CryoStor CS10 (STEMCELL Technologies 07930) freezing media.
For the glass controls in the experiments—sterile rh‐Vitronectin (Gibco, Life Technologies, A14700) was used to coat glass cover slips. In case of all experiments, cells were dissociated into a single cell suspension using StemPro Accutase (Gibco A1110501) cell dissociation reagent to facilitate cell counting. In case of single cell dissociation, cells were always seeded with 10 µm Rock inhibitor Y27632 (ATCC ACS‐3030).
+ Open protocol
+ Expand
5

Kidney Organoid Differentiation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Work with iPS and ES cells was conducted under the approval and auspices of the University of Washington Embryonic Stem Cell Research Oversight Committee. Specific cell lines used in this study are described below and were sourced from commercially available iPS and ES cell lines obtained with informed consent. Stem cell stocks were maintained in mTeSR1 media with daily media changes and passaging using Accutase (STEMCELL Technologies). One thousand to six thousand cells per well were placed in each 24-well plate precoated with 300 μL of DMEM-F12 containing 0.2 mg/mL Matrigel and sandwiched the following day with 0.2 mg/mL Matrigel in mTeSR1 (STEMCELL Technologies) to produce scattered, isolated spheroid colonies. Forty-eight hours after sandwiching, spheroids were treated with 12 μM CHIR99021 (Tocris Bioscience) for 36 hours, then changed to RB (Advanced RPMI + 1× Glutamax + 1× B27 Supplement, all from Thermo Fisher Scientific) and replaced every 3 days thereafter. Organoids were differentiated for 21 days from the time of plating, at which time tubular structures had formed. Gene-edited PKD2−/− organoids were picked from the adherent plate at day 21, placed in suspension culture with RB media replaced every 3 days until day 30 when cyst growth was prominent (37 (link)).
+ Open protocol
+ Expand
6

Generation and Culture of Human iPSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human iPSCs lines were derived from control (WTC11, WT1323) and FOP patients (FOP1–1, FOP3–2), as previously described (Matsumoto et al., 2013 (link); Miyaoka et al., 2014 (link)). Cells were cultured on feeder layers of irradiated SNL (mouse fibroblast STO cell line transformed with neomycin resistance and murine LIF genes) in mTeSR1 or mTeSR plus (StemCell Technologies) (McMahon and Bradley, 1990 (link)). Cells were passaged every 3–5 days using Accutase (StemCell Technologies). ROCK inhibitor Y-27632 (10 μM, StemCell Technologies) dissolved in 100 % DMSO was added to mTeSR1 or mTeSR plus at the time of passaging and removed on the following day. To remove SNL, hiPSCs were passaged on growth-factor-reduced Matrigel-coated plates (Corning, 150–300 ug/ml, 40 min coating) at least twice before use in differentiation into macrophages.
+ Open protocol
+ Expand
7

Directed Differentiation of hPSCs into Spheroid Colonies

Check if the same lab product or an alternative is used in the 5 most similar protocols
Work with hPSC was performed under the approval and auspices of the University of Washington Embryonic Stem Cell Research Oversight Committee. Specific cell lines used in this study are described below and are sourced from commercially available hPSC obtained with informed consent. hPSC stocks were maintained in mTeSR1 media with daily media changes and weekly passaging using Accutase or ReLeSR (STEMCELL Technologies, Vancouver). 5,000–20,000 hPSCs per well were placed in each 24-well plate pre-coated with 300 µL of DMEM-F12 containing 0.2 mg/mL Matrigel and sandwiched the following day with 0.2 mg/mL Matrigel in mTeSR1 (STEMCELL Technologies, Vancouver) to produce scattered, isolated spheroid colonies. 48 hrs after sandwiching, hPSC spheroids were treated with 12μM CHIR99021 (Tocris Bioscience) for 36 h, then changed to RB (Advanced RPMI + 1X Glutamax + 1X B27 Supplement, all from Thermo Fisher Scientific) after 48 h, and replaced with fresh RB every 3 days thereafter.
+ Open protocol
+ Expand
8

Efficient Genome Editing in SMA-iPSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
The SMA-iPSCs used in this study were described previously [20 (link)]. They were dissociated via TrypLE Select (Life Technologies, Grand Island, NY, USA) at 37 °C for 5 min. Single cells were counted and resuspended in 100 µL of the reagent from Human Stem Cell Nucleofector Kit 2 (Lonza, Alpharetta, GA, USA) for nucleofection by using Nucleofector II (Lonza, Alpharetta, GA, USA) set at B016 program. Then, 6 µg of pCMV-PE2 plasmid and 2 µg of pegRNA plasmid (1527N or 1327N) were used to transfect 1 × 106 cells. The transfected cells were cultured on Matrigel (Corning, NY, USA)-coated wells in mTeSR1 (STEMCELL Technologies, Vancouver, Canada). After 2 days, the cells were dissociated into single cells and counted. Subsequently, 500 cells were seeded in a 60 mm culture dish with an mTeSR1 medium supplemented with 10% CloneR (STEMCELL Technologies, Vancouver, Canada). After 14 days, clones were mechanically selected, expanded, and identified through PCR and Sanger sequencing of the modified targeted genome sequences.
+ Open protocol
+ Expand
9

iPSC UBQLN2 Gene Editing

Check if the same lab product or an alternative is used in the 5 most similar protocols
The sgRNA for UBQLN2 was designed using the CRISPR design tool (http://chopchop.cbu.uib.no. accessed on 8 November 2018), then the sgRNA oligonucleotides were annealed and ligated into lentiCRISPR v2 plasmids (Addgene, 52961, Cambridge, MA, USA), and sequenced via Sanger sequencing to confirm that no errors were introduced. After TrypLETM Select (Gibco, Grand Island, NY, USA) was used to detach WT iPSCs into a single cell, 1 × 106 cells, 1 μL of 40 μM ssODN, and 5 μg of leti-UBQLN2-sgRNA-cas9 plasmid were added to 18 μL Supplement 1 and 82 μL Solution 2 of Human Stem Cell Nucleofector Kit 2 (Lonza). The transfer procedure was B-016. The cells were seeded on Matrigel (BD Biosciences)-coated 6-well plates in mTeSR1 (STEMCELL Technologies, Vancouver, BC, Canada), containing 10 μm Y27632 for 24 h, then selected using mTeSR1 with a final concentration of 0.3 μg/mL puromycin. When the confluence of cells reached 70%, the cells were detached with TrypLETM Select. One thousand cells were seeded on a Matrigel-coated 6 cm dish in mTeSR1 containing 10% clone R (Stem cell) for four days and then replaced with mTeSR1 without clone R every day until clones were picked.
+ Open protocol
+ Expand
10

Culturing hESCs and HEK293FT Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Female H9 (WA09; RRID: CVCL_9773) hESCs were obtained from WiCell and cultured in either mTeSR1 (Stem Cell Technologies 85850) for at least one passage before differentiation into CNCCs or mTeSR Plus (Stem Cell Technologies 100–0276) for gene editing, single-cell cloning, expansion and maintenance. hESCs were grown on Matrigel growth factor reduced basement membrane matrix (Corning 354230) at 37 °C. hESCs were fed every day for mTeSR1 or every 2 days for mTeSR Plus and passaged every 5–6 days using ReLeSR (Stem Cell Technologies 05872).
HEK293FT cells were obtained from Invitrogen (R70007) and cultured in complete medium (DMEM-HG (GE Healthcare Life Science SH30243.01), 10% FBS, 1× Non-essential amino acids (Gibco 1114-0050), 1× GlutaMAX (Gibco 4109-0036), 1× antibiotic–antimycotic (Gibco 1524-0062)). Cells were fed every other day and passaged every 2–3 days using trypsin–EDTA (Gibco 25200072).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!